Hydroxychloroquine Seller’s Contract Claims Survive Maker’s Bid For Dismissal
TRENTON, N.J. — Applying the economic loss doctrine to a pharmaceutical supplier’s allegations that a manufacturer committed fraud as to a contract for the purchase of large quantities of hydroxychloroquine and...To view the full article, register now.
Already a subscriber? Click here to view full article